Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. A Systematic Review of the Management of Autonomic Dysreflexia Following Spinal Cord Injury

A Systematic Review of the Management of Autonomic Dysreflexia Following Spinal Cord Injury

Arch Phys Med Rehabil, 2009 · DOI: 10.1016/j.apmr.2008.10.017 · Published: April 1, 2009

Spinal Cord InjuryNeurologyRehabilitation

Simple Explanation

Autonomic dysreflexia (AD) is a clinical emergency in individuals with spinal cord injury (SCI), particularly at or above T6. It involves acute elevation of blood pressure and either slow or rapid heart rate. The review examines strategies to prevent and manage AD, including both pharmacological and non-pharmacological interventions. The initial non-pharmacological management includes positioning the patient upright, loosening tight clothing, and eliminating any precipitating stimulus. When non-pharmacological measures fail and systolic blood pressure remains elevated, antihypertensive drugs may be used. A variety of preventative and management options exist, but are predominantly supported by evidence from non-controlled trials.

Study Duration
Not specified
Participants
31 studies assessed
Evidence Level
Systematic Review

Key Findings

  • 1
    Preventative strategies for AD triggered by common stimuli (e.g., urogenital system) are primarily supported by Level 4 and Level 5 evidence.
  • 2
    Initial acute non-pharmacological management of AD is supported by clinical consensus and physiological data (Level 5 evidence).
  • 3
    Antihypertensive drugs are supported by Level 1 (prazosin) and Level 2 evidence (nifedipine and prostaglandin E2) in the presence of sustained elevated blood pressure.

Research Summary

This systematic review evaluates clinical evidence on strategies to prevent and manage autonomic dysreflexia (AD) following spinal cord injury (SCI). The review included 31 studies, with the majority being non-RCTs. Preventative strategies were primarily supported by lower-level evidence, while non-pharmacological management was based on clinical consensus. Pharmacological interventions like prazosin and nifedipine were supported by Level 1 and 2 evidence, respectively. The authors conclude that more rigorous trials are needed to strengthen the evidence base for AD management.

Practical Implications

Clinical Management

Emphasizes the importance of early recognition and management of AD, including non-pharmacological and pharmacological interventions.

Preventative Measures

Highlights the need for careful evaluation of individuals with SCI to identify and eliminate specific triggers for AD.

Future Research

Calls for more rigorous, controlled trials to determine the most effective agents and therapies for AD prevention and management.

Study Limitations

  • 1
    Limited number of RCTs available.
  • 2
    Many interventions supported by lower levels of evidence.
  • 3
    Lack of controlled trials evaluating non-pharmacological interventions.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury